2026· Iranian Journal of Basic Medical Sciences· Vol 29, pp. 1510 - 1520· 0 citations· 19 references
Medicine
TL;DR
A validated lipid-metabolism-based diagnostic signature with potential for early detection, molecular stratification, and mechanistic investigation is revealed.
Abstract
Objective(s): To identify lipid metabolism-related biomarkers of diabetic nephropathy (DN), develop and validate a diagnostic model, and further explore immune infiltration patterns and molecular subtypes of DN. Materials and Methods: Multiple public transcriptomic datasets were integrated to identify lipid metabolism-related biomarkers for DN using differential expression analysis, weighted gene co-expression network analysis, and machine learning. A diagnostic model was then constructed from these biomarkers, and its performance was evaluated using ROC curve and nomogram analyses, followed by validation in an independent cohort. In addition, immune cell infiltration was assessed with the CIBERSORT algorithm, and consensus clustering identified molecular subtypes of DN. Finally, the findings were validated in a model of type 2 diabetes. Results: A total of 28 lipid metabolism–related differentially expressed genes were identified, and five hub biomarkers (G0S2, PTGDS, CA2, CYP27B1, and HSD17B14) were screened and demonstrated favorable diagnostic performance in both training and validation cohorts. Functional enrichment analysis revealed that these genes were mainly involved in fatty acid metabolism and PPAR signaling pathways. Immune infiltration analysis revealed significant correlations between dysregulated lipid metabolism and immune cell infiltration in DN. Consensus clustering identified distinct molecular subtypes of DN with different lipid metabolic characteristics. Critically, bioinformatic predictions were validated in db/db mice, showing significantly elevated mRNA and protein levels of all five biomarkers in DN kidneys. Conclusion: Our findings reveal a validated lipid-metabolism-based diagnostic signature with potential for early detection, molecular stratification, and mechanistic investigation.
Background Ischemic stroke (IS) is a leading cause of death and disability worldwide, yet reliable early diagnostic biomarkers remain lacking. This study employed non-targeted metabolomics and machine learning to characterize metabolic profiles and identify diagnostic biomarkers for IS. Methods Non-targeted metabolomic...
Xiang-Jun Kong, Liang-Ying Zhang, Xing-Wang Li et al.· Frontiers in Genetics· 0 citations
This study linked cation homeostasis with DR, providing a potential research direction for the early diagnosis and treatment of DR and identified DUSP4 and NID1 as biomarkers, providing potential molecular clues for the exploration of therapeutic strategies for DR.
Results indicate that CTSG and LTF may serve as promising diagnostic biomarkers for T1DM, and functional enrichment analysis showed that immune activation played an important role in T1DM.
Jia-Ci Li, Shu-Yue Zhang, Xue-Tao Wang et al.· PeerJ· 0 citations
Background Emerging evidence indicates that hypoxia- and cuproptosis-related molecular alterations may contribute to diabetic retinopathy (DR). This study aimed to identify biomarkers associated with these processes and investigate their biological relevance in DR. Methods The DR-related datasets GSE189005 and GSE22152...
Rong Feng, Xia Wang, Xiao-Dong Li et al.· PLoS ONE· 0 citations
B2M, FTL, SH3BGRL3, and SOD2 were recognized as diagnostic markers for diabetes based on LASSO regression and the support vector machine recursive feature elimination (SVM-RFE) feature selection algorithm.
Juan Feng, Tian-Hang Zhao, Si-En Lai et al.· Brazilian journal of medical...· 0 citations
This hypoxia-associated seven-gene signature showed diagnostic potential and reflected immune and molecular heterogeneity in DKD and was associated with macrophage- and neutrophil-related immune remodeling.
Yue Ji, Jia-Kun Zhang, Xi Guo et al.· Diabetes Research and Clinic...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.